Opdivo Approved for Advanced Kidney Cancer

TUESDAY, Nov. 24, 2015 — Opdivo (nivolumab) has been approved to treat advanced renal cell carcinoma, the most common type of kidney cancer.
The drug targets proteins that would otherwise hinder the body’s immune system in fighting cancer cells,…
Source: Topamax